Bullish on Ranbaxy: Dilip Bhat, Prabhudas Lilladher

In a chat with ET Now, Dilip Bhat, Joint Managing Director, Prabhudas Lilladher, shares his views on Ranbaxy Laboratories Limited.

ET Now: What is the call on Ranbaxy?

Dilip Bhat: The idea is to find something which can give a very decent return. So, within that space Ranbaxy is a good pick. It is in a very structural bull kind of a phase with the core profits also likely to more than double in three years.